\-\ Texto\\:\\ \ \(0\)\
\-\ usually\\ when\\ symptomatic\\,\\ biopsy\\ and\\ curettage\\ are\\ the\\ main\\ treatment\\ options\\.\\ the\\ patient\\ had\\ a\\ curettage\\ of\\ the\\ cuboid\\ with\\ placement\\ of\\ bone\\ graft\\ material\\ to\\ help\\ structurally\\ support\\ her\\ foot\\.\\ \ \(0\)\
\-\ follow\\-up\\ included\\ additional\\ imaging\\ to\\ ensure\\ proper\\ healing\\ as\\ well\\ as\\ evaluating\\ for\\ recurrence\\ of\\ the\\ aneurysmal\\ bone\\ cyst\\.\\ radiographs\\ showed\\ the\\ cement\\ in\\ the\\ region\\ of\\ the\\ curettage\\ and\\ no\\ recurrence\\ of\\ lucency\\.\ \(0\)\
\-\ ap\\,\\ lateral\\ and\\ oblique\\ radiographic\\ views\\ of\\ the\\ right\\ foot\\ show\\ a\\ well\\-defined\\ radiolucent\\ medullary\\ mass\\ of\\ the\\ cuboid\\ bone\\ that\\ expands\\ the\\ cortex\\ but\\ does\\ not\\ cause\\ cortical\\ disruption\\.\\ there\\ is\\ a\\ narrow\\ zone\\ of\\ transition\\.\\ follow\\-up\\ radiographs\\ after\\ curettage\\ show\\ the\\ cement\\ placement\\ in\\ the\\ region\\ of\\ curettage\\ without\\ recurrence\\ of\\ the\\ aneurysmal\\ bone\\ cyst\\.\ \(0\)\
\-\ axial\\ ct\\ of\\ the\\ right\\ foot\\ with\\ bone\\ windows\\ show\\ a\\ lytic\\ mass\\ expanding\\ the\\ cuboid\\ bone\\ \\ and\\ measuring\\ 3\\ cm\\ x\\ 2\\.6\\ cm\\ in\\ greatest\\ dimension\\ with\\ multiple\\ fluid\\-fluid\\ levels\\.\\ the\\ cortex\\ is\\ thinned\\.\\ soft\\ tissue\\ windows\\ suggest\\ fluid\\-fluid\\ levels\\.\\ no\\ matrix\\ calcifications\\ are\\ seen\\.\\ these\\ findings\\ are\\ consistent\\ with\\ an\\ aneurysmal\\ bone\\ \\ cyst\\.\ \(0\)\
\-\ aneurysmal\\ bone\\ cyst\ \(11\)\
\-\ simple\\ bone\\ cyst\ \(7\)\
\-\ giant\\ cell\\ tumor\ \(18\)\
\-\ eosinohilic\\ granuloma\ \(0\)\
\-\ osteoblastoma\ \(15\)\
\-\ chondroblastoma\ \(12\)\
\-\ infection\\ \\(brodie\\‚\\Ä\\ôs\\ abscess\\)\ \(0\)\
\-\ 11y\\/o\\ female\\ with\\ h\\/o\\ trauma\\ now\\ with\\ persistent\\ pain\\.\ \(1\)\
\-\ aneurysmal\\ bone\\ cysts\\ \\(abc\\)\\ are\\ described\\ as\\ a\\ benign\\ \\‚\\Ä\\úvascular\\ reactive\\ lesion\\.\\‚\\Ä\\ù\\ they\\ usually\\ present\\ as\\ lytic\\ expansile\\ masses\\ found\\ most\\ commonly\\ in\\ the\\ metaphysis\\ of\\ the\\ tibia\\ and\\ femur\\ and\\ posterior\\ portions\\ of\\ the\\ vertebrae\\.\\ they\\ usually\\ are\\ non\\-aggressive\\ in\\ appearance\\ and\\ do\\ not\\ disrupt\\ the\\ cortex\\.\\ the\\ mass\\ may\\ have\\ a\\ thin\\ rim\\ of\\ cortex\\ remaining\\ giving\\ it\\ an\\ \\‚\\Ä\\úegg\\-shell\\‚\\Ä\\ù\\ appearance\\.\\ the\\ lytic\\ portion\\ of\\ the\\ mass\\ has\\ also\\ been\\ described\\ as\\ having\\ a\\ \\‚\\Ä\\úsoap\\-bubble\\‚\\Ä\\ù\\ appearance\\.\\ \\ \ \(0\)\
\-\ \\	ct\\ is\\ also\\ helpful\\ in\\ the\\ evaluation\\ of\\ this\\ lesion\\ since\\ it\\ may\\ show\\ more\\ clearly\\ that\\ the\\ matrix\\ has\\ no\\ calcifications\\ and\\ show\\ preservation\\ of\\ the\\ cortex\\.\\ ct\\ can\\ sometimes\\ show\\ the\\ fluid\\-fluid\\ levels\\ which\\ represent\\ blood\\ products\\ in\\ heterogeneous\\ stages\\ of\\ breakdown\\ on\\ histological\\ examination\\.\ \(0\)\
\-\ \\	mri\\ confirms\\ the\\ contours\\ and\\ shows\\ the\\ fluid\\-fluid\\ levels\\,\\ while\\ also\\ demonstrating\\ the\\ surrounding\\ soft\\ tissues\\ more\\ clearly\\ than\\ ct\\.\\ this\\ is\\ because\\ of\\ the\\ improved\\ contrast\\ seen\\ on\\ the\\ mr\\ images\\.\\ it\\ is\\ also\\ the\\ modality\\ of\\ choice\\ for\\ identifying\\ nodularity\\ within\\ the\\ wall\\ of\\ the\\ cyst\\,\\ which\\ may\\ direct\\ future\\ biopsy\\.\ \(0\)\
\-\ \\	aneurysmal\\ bone\\ cysts\\ are\\ accompanied\\ by\\ associated\\ tumor\\ approximately\\ 20\\-30\\%\\ of\\ the\\ time\\.\\ these\\ associated\\ tumors\\ include\\,\\ most\\ commonly\\ giant\\ cell\\ tumors\\,\\ but\\ may\\ also\\ include\\ fibrous\\ dysplasia\\,\\ chondroblastoma\\,\\ osteoblastoma\\,\\ osteosarcma\\,\\ and\\ chondrosarcoma\\.\\ \ \(0\)\
\-\ \\	treatment\\ of\\ abc\\‚\\Ä\\ôs\\ generally\\ treated\\ surgically\\,\\ although\\ they\\ may\\ also\\ be\\ observed\\ for\\ growth\\ rate\\ and\\ further\\ involvement\\.\\ if\\ there\\ are\\ questions\\ regarding\\ the\\ exact\\ diagnosis\\ and\\ there\\ appears\\ to\\ be\\ an\\ associated\\ lesion\\,\\ then\\ biopsy\\ should\\ be\\ performed\\.\\ if\\ a\\ malignancy\\ is\\ found\\,\\ the\\ patient\\ has\\ a\\ wide\\ resection\\ of\\ the\\ tumor\\.\\ if\\ the\\ abc\\ is\\ symptomatic\\ and\\ no\\ malignancy\\ is\\ seen\\,\\ curettage\\ is\\ the\\ treatment\\ of\\ choice\\.\\ \\ selective\\ embolization\\,\\ intralesional\\ injection\\,\\ irradiation\\,\\ and\\ en\\ bloc\\ resection\\ have\\ also\\ been\\ described\\.\\ recurrence\\ rates\\ are\\ not\\ uncommon\\ with\\ these\\ bone\\ cysts\\,\\ occurring\\ approximately\\ 0\\-30\\%\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ the\\:\\ 0\\.31999400291819613\ \(0\)\
\-\ curettage\\:\\ 0\\.25875156615977996\ \(0\)\
\-\ bone\\:\\ 0\\.25610415611351933\ \(0\)\
\-\ aneurysmal\\:\\ 0\\.23023444360530845\ \(0\)\
\-\ of\\:\\ 0\\.19136266981726885\ \(0\)\
\-\ cortex\\:\\ 0\\.15925820153304684\ \(0\)\
\-\ cuboid\\:\\ 0\\.15671711387021092\ \(0\)\
\-\ show\\:\\ 0\\.14898416816355992\ \(0\)\
\-\ abc\\:\\ 0\\.14620904478657765\ \(0\)\
\-\ cyst\\:\\ 0\\.13538178616085778\ \(0\)\
\-\ recurrence\\:\\ 0\\.129176702757108\ \(0\)\
\-\ also\\:\\ 0\\.12878791210744306\ \(0\)\
\-\ levels\\:\\ 0\\.1240378715256654\ \(0\)\
\-\ are\\:\\ 0\\.11873696054274889\ \(0\)\
\-\ and\\:\\ 0\\.11315504576923652\ \(0\)\
\-\ cement\\:\\ 0\\.10447807591347394\ \(0\)\
\-\ lytic\\:\\ 0\\.09884312948705525\ \(0\)\
\-\ may\\:\\ 0\\.0984178922906732\ \(0\)\
\-\ is\\:\\ 0\\.09640559489543025\ \(0\)\
\-\ described\\:\\ 0\\.09520723789985176\ \(0\)\
\-\ chondroblastoma\\:\\ 0\\.09423089933055115\ \(0\)\
\-\ foot\\:\\ 0\\.09272060604667096\ \(0\)\
\-\ cysts\\:\\ 0\\.08891925905425081\ \(0\)\
\-\ osteoblastoma\\:\\ 0\\.08891314600662571\ \(0\)\
\-\ windows\\:\\ 0\\.084725191812394\ \(0\)\
\-\ they\\:\\ 0\\.08384380629886803\ \(0\)\
\-\ biopsy\\:\\ 0\\.08225331151681374\ \(0\)\
\-\ matrix\\:\\ 0\\.0786917715707247\ \(0\)\
\-\ as\\:\\ 0\\.07856812958078821\ \(0\)\
\-\ choice\\:\\ 0\\.07417742594430528\ \(0\)\
\-\ usually\\:\\ 0\\.07387181330162002\ \(0\)\
\-\ clearly\\:\\ 0\\.073684660223226\ \(0\)\
\-\ appearance\\:\\ 0\\.07074159188817752\ \(0\)\
\-\ giant\\:\\ 0\\.06977982939347117\ \(0\)\
\-\ if\\:\\ 0\\.06817924255825294\ \(0\)\
\-\ in\\:\\ 0\\.06811268047796595\ \(0\)\
\-\ these\\:\\ 0\\.06626361584570133\ \(0\)\
\-\ eosinohilic\\:\\ 0\\.06255237415676064\ \(0\)\
\-\ osteosarcma\\:\\ 0\\.06255237415676064\ \(0\)\
\-\ associated\\:\\ 0\\.06184860000652847\ \(0\)\
\-\ tumor\\:\\ 0\\.06137723637310003\ \(0\)\
\-\ placement\\:\\ 0\\.06108656844393527\ \(0\)\
\-\ symptomatic\\:\\ 0\\.06015329433513461\ \(0\)\
\-\ it\\:\\ 0\\.06006627996752363\ \(0\)\
\-\ mass\\:\\ 0\\.05976256282944641\ \(0\)\
\-\ ct\\:\\ 0\\.05956481378110758\ \(0\)\
\-\ malignancy\\:\\ 0\\.05856479568642126\ \(0\)\
\-\ commonly\\:\\ 0\\.05788549536940149\ \(0\)\
\-\ structurally\\:\\ 0\\.05779952039768207\ \(0\)\
\-\ tumors\\:\\ 0\\.05753319394172109\ \(0\)\
\-\ calcifications\\:\\ 0\\.0570931400232578\ \(0\)\
\-\ bloc\\:\\ 0\\.05626944324174367\ \(0\)\
\-\ lesion\\:\\ 0\\.05625688049102058\ \(0\)\
\-\ treatment\\:\\ 0\\.05589673301050196\ \(0\)\
\-\ seen\\:\\ 0\\.055244169571805876\ \(0\)\
\-\ with\\:\\ 0\\.053613562510727936\ \(0\)\
\-\ has\\:\\ 0\\.05359889753629359\ \(0\)\
\-\ disrupt\\:\\ 0\\.05223903795673697\ \(0\)\
\-\ brodie\\:\\ 0\\.0515165894826651\ \(0\)\
\-\ no\\:\\ 0\\.050878177001974854\ \(0\)\
\-\ radiographs\\:\\ 0\\.05073810752250946\ \(0\)\
\-\ found\\:\\ 0\\.05061754554078781\ \(0\)\
\-\ thinned\\:\\ 0\\.05026642541813095\ \(0\)\
\-\ resection\\:\\ 0\\.05014562501156444\ \(0\)\
\-\ approximately\\:\\ 0\\.04991561815930918\ \(0\)\
\-\ intralesional\\:\\ 0\\.049717579091228675\ \(0\)\
\-\ expands\\:\\ 0\\.04920942676239143\ \(0\)\
\-\ questions\\:\\ 0\\.04920942676239143\ \(0\)\
\-\ breakdown\\:\\ 0\\.048736348262192544\ \(0\)\
\-\ irradiation\\:\\ 0\\.048293812879524924\ \(0\)\
\-\ be\\:\\ 0\\.047601394377190756\ \(0\)\
\-\ contours\\:\\ 0\\.047115449665275574\ \(0\)\
\-\ region\\:\\ 0\\.04679288244529741\ \(0\)\
\-\ there\\:\\ 0\\.04669044534273071\ \(0\)\
\-\ include\\:\\ 0\\.046545374155169066\ \(0\)\
\-\ selective\\:\\ 0\\.046429185541918876\ \(0\)\
\-\ not\\:\\ 0\\.04632425468219765\ \(0\)\
\-\ been\\:\\ 0\\.045576936342239686\ \(0\)\
\-\ giving\\:\\ 0\\.044964725332150096\ \(0\)\
\-\ cm\\:\\ 0\\.044927639357214375\ \(0\)\
\-\ an\\:\\ 0\\.04487159796280356\ \(0\)\
\-\ cell\\:\\ 0\\.04475043009478947\ \(0\)\
\-\ expanding\\:\\ 0\\.044456573003312856\ \(0\)\
\-\ identifying\\:\\ 0\\.04332996036337254\ \(0\)\
\-\ nodularity\\:\\ 0\\.04332996036337254\ \(0\)\
\-\ histological\\:\\ 0\\.04312526102662998\ \(0\)\
\-\ more\\:\\ 0\\.042955932563753116\ \(0\)\
\-\ exact\\:\\ 0\\.04292649584737445\ \(0\)\
\-\ proper\\:\\ 0\\.042733330438579825\ \(0\)\
\-\ radiolucent\\:\\ 0\\.042733330438579825\ \(0\)\
\-\ preservation\\:\\ 0\\.042733330438579825\ \(0\)\
\-\ accompanied\\:\\ 0\\.042733330438579825\ \(0\)\
\-\ stages\\:\\ 0\\.04184156673123121\ \(0\)\
\-\ soft\\:\\ 0\\.04164730403202481\ \(0\)\
\-\ en\\:\\ 0\\.04151498507869778\ \(0\)\
\-\ products\\:\\ 0\\.04135734782476652\ \(0\)\
\-\ regarding\\:\\ 0\\.04105254570949025\ \(0\)\
\-\ transition\\:\\ 0\\.04090507941200722\ \(0\)\
\-\ graft\\:\\ 0\\.0407607178999738\ \(0\)\
\-\ ensure\\:\\ 0\\.0407607178999738\ \(0\)\
\-\ rates\\:\\ 0\\.0407607178999738\ \(0\)\
\-\ most\\:\\ 0\\.04071259300581571\ \(0\)\
\-\ vertebrae\\:\\ 0\\.04048080480856954\ \(0\)\
\-\ dimension\\:\\ 0\\.040345019806157435\ \(0\)\
\-\ occurring\\:\\ 0\\.03946310092253629\ \(0\)\
\-\ evaluating\\:\\ 0\\.03934588578536235\ \(0\)\
\-\ future\\:\\ 0\\.03923064074403539\ \(0\)\
\-\ greatest\\:\\ 0\\.0391173006668958\ \(0\)\
\-\ have\\:\\ 0\\.03907953491882553\ \(0\)\
\-\ but\\:\\ 0\\.038684222610905046\ \(0\)\
\-\ modality\\:\\ 0\\.03868179441713312\ \(0\)\
\-\ narrow\\:\\ 0\\.03837240726755141\ \(0\)\
\-\ support\\:\\ 0\\.03798047667950125\ \(0\)\
\-\ wide\\:\\ 0\\.037885896993129456\ \(0\)\
\-\ well\\:\\ 0\\.037878730222138474\ \(0\)\
\-\ zone\\:\\ 0\\.037792604145186565\ \(0\)\
\-\ confirms\\:\\ 0\\.037792604145186565\ \(0\)\
\-\ portions\\:\\ 0\\.03717284799763473\ \(0\)\
\-\ remaining\\:\\ 0\\.03717284799763473\ \(0\)\
\-\ helpful\\:\\ 0\\.03708871297215264\ \(0\)\
\-\ sometimes\\:\\ 0\\.03660449406568794\ \(0\)\
\-\ healing\\:\\ 0\\.03652701393567978\ \(0\)\
\-\ surgically\\:\\ 0\\.036299691950411675\ \(0\)\
\-\ help\\:\\ 0\\.03593680735425918\ \(0\)\
\-\ metaphysis\\:\\ 0\\.03593680735425918\ \(0\)\
\-\ chondrosarcoma\\:\\ 0\\.0358664793680222\ \(0\)\
\-\ which\\:\\ 0\\.0355713757853821\ \(0\)\
\-\ for\\:\\ 0\\.03556578543987885\ \(0\)\
\-\ simple\\:\\ 0\\.035393400867823326\ \(0\)\
\-\ granuloma\\:\\ 0\\.035393400867823326\ \(0\)\
\-\ expansile\\:\\ 0\\.035393400867823326\ \(0\)\
\-\ uncommon\\:\\ 0\\.035393400867823326\ \(0\)\
\-\ disruption\\:\\ 0\\.03532840589258689\ \(0\)\
\-\ options\\:\\ 0\\.03526402120781842\ \(0\)\
\-\ observed\\:\\ 0\\.03482950092664588\ \(0\)\
\-\ improved\\:\\ 0\\.03471024716345772\ \(0\)\
\-\ medullary\\:\\ 0\\.034593032026283776\ \(0\)\
\-\ direct\\:\\ 0\\.03447778698495682\ \(0\)\
\-\ main\\:\\ 0\\.03408903163129926\ \(0\)\
\-\ embolization\\:\\ 0\\.03408903163129926\ \(0\)\
\-\ injection\\:\\ 0\\.03403525160228921\ \(0\)\
\-\ that\\:\\ 0\\.03394832931359138\ \(0\)\
\-\ oblique\\:\\ 0\\.033876396963792244\ \(0\)\
\-\ included\\:\\ 0\\.03382425284521539\ \(0\)\
\-\ having\\:\\ 0\\.03372113934498752\ \(0\)\
\-\ lucency\\:\\ 0\\.033670158303090295\ \(0\)\
\-\ reactive\\:\\ 0\\.03356931944827996\ \(0\)\
\-\ tibia\\:\\ 0\\.0334207883292173\ \(0\)\
\-\ generally\\:\\ 0\\.03313304323405088\ \(0\)\
\-\ material\\:\\ 0\\.032947709829018415\ \(0\)\
\-\ represent\\:\\ 0\\.032548164672114334\ \(0\)\
\-\ do\\:\\ 0\\.03241999423855615\ \(0\)\
\-\ demonstrating\\:\\ 0\\.03225274403120928\ \(0\)\
\-\ growth\\:\\ 0\\.03225274403120928\ \(0\)\
\-\ femur\\:\\ 0\\.03208947635253443\ \(0\)\
\-\ suggest\\:\\ 0\\.03177416017660121\ \(0\)\
\-\ rim\\:\\ 0\\.031148699437581993\ \(0\)\
\-\ views\\:\\ 0\\.030873007287245652\ \(0\)\
\-\ tissues\\:\\ 0\\.030839312288000284\ \(0\)\
\-\ thin\\:\\ 0\\.030447381699950125\ \(0\)\
\-\ fibrous\\:\\ 0\\.03038418384660795\ \(0\)\
\-\ additional\\:\\ 0\\.030321563150670965\ \(0\)\
\-\ measuring\\:\\ 0\\.030259509165635443\ \(0\)\
\-\ persistent\\:\\ 0\\.030137060937657015\ \(0\)\
\-\ dysplasia\\:\\ 0\\.029957393404379147\ \(0\)\
\-\ rate\\:\\ 0\\.029639753018083602\ \(0\)\
\-\ to\\:\\ 0\\.029335538234706356\ \(0\)\
\-\ radiographic\\:\\ 0\\.029019648511827777\ \(0\)\
\-\ appears\\:\\ 0\\.0286434892018295\ \(0\)\
\-\ since\\:\\ 0\\.028333384388471078\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.028310101111266795\ \(0\)\
\-\ involvement\\:\\ 0\\.028310101111266795\ \(0\)\
\-\ ap\\:\\ 0\\.028081515992800253\ \(0\)\
\-\ cortical\\:\\ 0\\.028081515992800253\ \(0\)\
\-\ portion\\:\\ 0\\.027970018925629635\ \(0\)\
\-\ then\\:\\ 0\\.027688336535144915\ \(0\)\
\-\ because\\:\\ 0\\.027336622593455855\ \(0\)\
\-\ does\\:\\ 0\\.02704059452742321\ \(0\)\
\-\ this\\:\\ 0\\.026880795813787908\ \(0\)\
\-\ benign\\:\\ 0\\.026868924178702302\ \(0\)\
\-\ now\\:\\ 0\\.026850112319033902\ \(0\)\
\-\ cause\\:\\ 0\\.026646518134771497\ \(0\)\
\-\ masses\\:\\ 0\\.02662830585700432\ \(0\)\
\-\ although\\:\\ 0\\.02662830585700432\ \(0\)\
\-\ surrounding\\:\\ 0\\.026086458528921712\ \(0\)\
\-\ showed\\:\\ 0\\.026052928298057085\ \(0\)\
\-\ right\\:\\ 0\\.02593605633751116\ \(0\)\
\-\ vascular\\:\\ 0\\.025822698374429742\ \(0\)\
\-\ should\\:\\ 0\\.025522116334298448\ \(0\)\
\-\ further\\:\\ 0\\.025475837743228754\ \(0\)\
\-\ patient\\:\\ 0\\.02544387434542496\ \(0\)\
\-\ mr\\:\\ 0\\.025308772770393905\ \(0\)\
\-\ while\\:\\ 0\\.025278829847055186\ \(0\)\
\-\ abscess\\:\\ 0\\.025116440978833098\ \(0\)\
\-\ examination\\:\\ 0\\.025029459873182187\ \(0\)\
\-\ her\\:\\ 0\\.024436432217213214\ \(0\)\
\-\ treated\\:\\ 0\\.024357616193727772\ \(0\)\
\-\ evaluation\\:\\ 0\\.023854130022640033\ \(0\)\
\-\ wall\\:\\ 0\\.023793716252550324\ \(0\)\
\-\ when\\:\\ 0\\.023627335715893732\ \(0\)\
\-\ infection\\:\\ 0\\.023627335715893732\ \(0\)\
\-\ on\\:\\ 0\\.02362641519307637\ \(0\)\
\-\ time\\:\\ 0\\.023184066541310566\ \(0\)\
\-\ performed\\:\\ 0\\.023140182112808896\ \(0\)\
\-\ shows\\:\\ 0\\.02295674455604245\ \(0\)\
\-\ trauma\\:\\ 0\\.022716126234344467\ \(0\)\
\-\ blood\\:\\ 0\\.022716126234344467\ \(0\)\
\-\ axial\\:\\ 0\\.022593859959889957\ \(0\)\
\-\ than\\:\\ 0\\.022172817655633358\ \(0\)\
\-\ consistent\\:\\ 0\\.02120870298218688\ \(0\)\
\-\ without\\:\\ 0\\.020631353419499864\ \(0\)\
\-\ imaging\\:\\ 0\\.02055591901131533\ \(0\)\
\-\ can\\:\\ 0\\.02052597608797661\ \(0\)\
\-\ tissue\\:\\ 0\\.020518510743147426\ \(0\)\
\-\ diagnosis\\:\\ 0\\.02027660611410361\ \(0\)\
\-\ posterior\\:\\ 0\\.02022637205391074\ \(0\)\
\-\ mri\\:\\ 0\\.020077840934848077\ \(0\)\
\-\ present\\:\\ 0\\.02007084764658428\ \(0\)\
\-\ had\\:\\ 0\\.019488211437971515\ \(0\)\
\-\ lateral\\:\\ 0\\.01941159702585457\ \(0\)\
\-\ findings\\:\\ 0\\.01930450471092244\ \(0\)\
\-\ multiple\\:\\ 0\\.019131683934450316\ \(0\)\
\-\ contrast\\:\\ 0\\.01900486808772946\ \(0\)\
\-\ after\\:\\ 0\\.018975016414336965\ \(0\)\
\-\ female\\:\\ 0\\.01887448195681516\ \(0\)\
\-\ images\\:\\ 0\\.01809299481842378\ \(0\)\
\-\ within\\:\\ 0\\.018014867290166707\ \(0\)\
\-\ by\\:\\ 0\\.016610225068942015\ \(0\)\
\-\ pain\\:\\ 0\\.01399655686273413\ \(0\)\
